Suchergebnisse - "Willoughby, Catherine E"

PubPharm (18)

1

Nonalcoholic steatohepatitis-related hepatocellular carcinoma : pathogenesis and treatment

enthalten in: Nature reviews. Gastroenterology & hepatology | 2023

von Llovet, J. | Willoughby, C. | Singal, A. | +5

2

Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma

enthalten in: Molecular cancer therapeutics | 2023

von Abril-Fornaguera, J. | Torrens, L. | Andreu-Oller, C. | +26

3

CXCR2 inhibition enables NASH-HCC immunotherapy

enthalten in: bioRxiv.org | 2022

von Leslie, J. | Mackey, J. | Jamieson, T. | +43

4

Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Esteban-Fabró, R. | Willoughby, C. | Piqué-Gili, M. | +10

5

CXCR2 inhibition enables NASH-HCC immunotherapy

enthalten in: Gut | 2022

von Leslie, J. | Mackey, J. | Jamieson, T. | +43

CommentIn: Nat Rev Gastroenterol Hepatol. 2022 Jul;19(7):415. - PMID 35610512

6

Corrigendum to 'Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis' [J Hepatol 75 (2021) 865-878

enthalten in: Journal of hepatology | 2021

von Pinyol, R. | Torrecilla, S. | Wang, H. | +32

ErratumFor: J Hepatol. 2021 Oct;75(4):865-878. - PMID 33992698

7

Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma

enthalten in: Hepatology (Baltimore, Md.) | 2021

von Torrens, L. | Montironi, C. | Puigvehí, M. | +17

8

Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

enthalten in: Journal of hepatology | 2021

von Pinyol, R. | Torrecilla, S. | Wang, H. | +32

CommentIn: Nat Rev Gastroenterol Hepatol. 2021 Jul;18(7):456. - PMID 34103708

9

Atezolizumab plus Bevacizumab : A Novel Breakthrough in Hepatocellular Carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Castet, F. | Willoughby, C. | Haber, P. | +1

CommentOn: Clin Cancer Res. 2021 Apr 1;27(7):1836-1841. - PMID 33139264

10

Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma

enthalten in: Hepatology | 2021

von Torrens, L. | Montironi, C. | Puigvehí, M. | +17